These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23110464)

  • 1. Venlafaxine and risk of upper gastrointestinal bleeding in elderly depression.
    Ghio L; Puppo S; Presta A
    Curr Drug Saf; 2012 Nov; 7(5):389-90. PubMed ID: 23110464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyponatremia with venlafaxine.
    Masood GR; Karki SD; Patterson WR
    Ann Pharmacother; 1998 Jan; 32(1):49-51. PubMed ID: 9475820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.
    de Abajo FJ; García-Rodríguez LA
    Arch Gen Psychiatry; 2008 Jul; 65(7):795-803. PubMed ID: 18606952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatraemia in elderly psychiatric patients treated with Selective Serotonin Reuptake Inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit.
    Kirby D; Harrigan S; Ames D
    Int J Geriatr Psychiatry; 2002 Mar; 17(3):231-7. PubMed ID: 11921151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
    Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
    Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML; Garfield LD; Teitelbaum S; Civitelli R; Mulsant BH; Reynolds CF; Dixon D; Doré P; Lenze EJ
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.
    Targownik LE; Bolton JM; Metge CJ; Leung S; Sareen J
    Am J Gastroenterol; 2009 Jun; 104(6):1475-82. PubMed ID: 19491861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine-induced hyponatremia.
    Gupta AK; Saravay SM
    J Clin Psychopharmacol; 1997 Jun; 17(3):223-5. PubMed ID: 9169969
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine and severe tinnitus.
    Ahmad S
    Am Fam Physician; 1995 Jun; 51(8):1830. PubMed ID: 7762476
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of serotonin syndrome caused by venlafaxine and lithium.
    Mekler G; Woggon B
    Pharmacopsychiatry; 1997 Nov; 30(6):272-3. PubMed ID: 9442552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible focal myositis in a patient taking venlafaxine.
    Jewell DP; Thompson IW; Sullivan BA; Bondeson J
    Rheumatology (Oxford); 2004 Dec; 43(12):1590-3. PubMed ID: 15564641
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis.
    Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N
    Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
    Pinzani V; Giniès E; Robert L; Peyrière H; Abbar M; Blayac JP
    Rev Med Interne; 2000 Mar; 21(3):282-4. PubMed ID: 10763190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conduction disturbances associated with venlafaxine.
    Combes A; Peytavin G; Théron D
    Ann Intern Med; 2001 Jan; 134(2):166-7. PubMed ID: 11177325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.